Florian Cabillic

Targeting RET in Patients With <i>RET</i>-Rearranged Lung Cancers: Results From the Global, Multicenter <i>RET</i> Registry

Oliver Gautschi, Julie Milia, Thomas Filleron et al. · Journal of Clinical Oncology · 2017 · 356 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances

Florian Cabillic, Audrey Gros, Frédéric Dugay et al. · Journal of Thoracic Oncology · 2014 · 150 citations · Full text

Medicine, Genetics, Oncology +14

DNAX accessory molecule‐1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vγ9Vδ2 T cells

Olivier Toutirais, Florian Cabillic, Gaëlle Le Friec et al. · European Journal of Immunology · 2009 · 126 citations

Life Sciences, Immunology, Oncology +15

Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry

Solène‐Florence Kammerer‐Jacquet, Sixte Thierry, Florian Cabillic et al. · Human Pathology · 2016 · 120 citations

Veterinary Medicine, Oncology, Pathology +13

Vγ9Vδ2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas

Françoise Bouet-Toussaint, Florian Cabillic, Olivier Toutirais et al. · Cancer Immunology Immunotherapy · 2007 · 105 citations · Full text

Life Sciences, Immunology, Oncology +16